Variation in KLK genes, prostate-specific antigen and risk of prostate cancer
- 1 September 2008
- journal article
- research article
- Published by Springer Science and Business Media LLC in Nature Genetics
- Vol. 40 (9), 1032-1034
- https://doi.org/10.1038/ng0908-1032
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Multiple newly identified loci associated with prostate cancer susceptibilityNature Genetics, 2008
- Multiple loci identified in a genome-wide association study of prostate cancerNature Genetics, 2008
- Tagging SNPs in the kallikrein genes 3 and 2 on 19q13 and their associations with prostate cancer in men of European originHuman Genetics, 2007
- PSA/KLK3 AREI promoter polymorphism alters androgen receptor binding and is associated with prostate cancer susceptibilityCarcinogenesis: Integrative Cancer Research, 2006
- Human Tissue Kallikreins: Physiologic Roles and Applications in CancerMolecular Cancer Research, 2004
- Association Between Genetic Polymorphisms in the Prostate-Specific Antigen Gene Promoter and Serum Prostate-Specific Antigen LevelsJNCI Journal of the National Cancer Institute, 2003
- Lead Times and Overdetection Due to Prostate-Specific Antigen Screening: Estimates From the European Randomized Study of Screening for Prostate CancerJNCI Journal of the National Cancer Institute, 2003
- Single Nucleotide Polymorphism of the Human Kallikrein-2 Gene Highly Correlates With Serum Human Kallikrein-2 Levels and in Combination Enhances Prostate Cancer DetectionJournal of Clinical Oncology, 2003
- Prostate cancer mortality reduction by screening: Power and time frame with complete enrollment in the European randomised screening for prostate cancer (ERSPC) trialInternational Journal of Cancer, 2001
- Screening for Prostate Cancer with Prostate-Specific Antigen — An Examination of the EvidenceNew England Journal of Medicine, 1995